Tacrolimus (Tac)

[Edit]

FK-506; Fujimycin; Prograf; Advagraf; Protopic

Tacrolimus (Tac)
Tacrolimus is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system and so lower the risk of organ rejection. It is a 23-membered macrolide lactone discovered in 1984 from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis. It reduces interleukin-2 (IL-2) production by T-cells.
Tacrolimus is chemically known as a macrolide. In T-cells, activation of the T-cell receptor normally increases intracellular calcium, which acts via calmodulin to activate calcineurin. Calcineurin then dephosphorylates the transcription factor NF-AT (nuclear factor of activated T-cells), which moves to the nucleus of the T-cell and increases the activity of genes coding for IL-2 and related cytokines.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Tacrolimus (Tac) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Tacrolimus (Tac) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Tacrolimus (Tac) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Tacrolimus (Tac) CLIA Kit Customized Service Offer
n/a ELISA Kit for Tacrolimus (Tac) ELISA Kit Customized Service Offer